BACKGROUND: Complement protein factor H (CFH) is a regulatory protein of the alternative complement pathway (AP); CFH mutations lead to a spectrum of different phenotypical manifestations of renal disease. CASE-DIAGNOSIS/TREATMENT: We report the case of a boy with a novel CFH gene mutation who presented with a membranoproliferative (MPGN) pattern of glomerular injury and developed 2 years later atypical hemolytic uremic syndrome (aHUS); this description shows that CFH alteration leads to two different renal diseases in the same patient. CONCLUSIONS: Our case suggests the possibility that complement dysregulation could determine different renal conditions, which may be part of the same disease spectrum. Early recognition of an evolution of glomerulopathies into aHUS may allow appropriate management and prevention of life-threatening consequences.
BACKGROUND:Complement protein factor H (CFH) is a regulatory protein of the alternative complement pathway (AP); CFH mutations lead to a spectrum of different phenotypical manifestations of renal disease. CASE-DIAGNOSIS/TREATMENT: We report the case of a boy with a novel CFH gene mutation who presented with a membranoproliferative (MPGN) pattern of glomerular injury and developed 2 years later atypical hemolytic uremic syndrome (aHUS); this description shows that CFH alteration leads to two different renal diseases in the same patient. CONCLUSIONS: Our case suggests the possibility that complement dysregulation could determine different renal conditions, which may be part of the same disease spectrum. Early recognition of an evolution of glomerulopathies into aHUS may allow appropriate management and prevention of life-threatening consequences.
Authors: Marina Noris; Jessica Caprioli; Elena Bresin; Chiara Mossali; Gaia Pianetti; Sara Gamba; Erica Daina; Chiara Fenili; Federica Castelletti; Annalisa Sorosina; Rossella Piras; Roberta Donadelli; Ramona Maranta; Irene van der Meer; Edward M Conway; Peter F Zipfel; Timothy H Goodship; Giuseppe Remuzzi Journal: Clin J Am Soc Nephrol Date: 2010-07-01 Impact factor: 8.237
Authors: Daniel P Gale; Elena Goicoechea de Jorge; H Terence Cook; Rubén Martinez-Barricarte; Andreas Hadjisavvas; Adam G McLean; Charles D Pusey; Alkis Pierides; Kyriacos Kyriacou; Yiannis Athanasiou; Konstantinos Voskarides; Constantinos Deltas; Andrew Palmer; Véronique Frémeaux-Bacchi; Santiago Rodriguez de Cordoba; Patrick H Maxwell; Matthew C Pickering Journal: Lancet Date: 2010-08-25 Impact factor: 79.321
Authors: Christine Skerka; Christoph Licht; Michael Mengel; Barbara Uzonyi; Stefanie Strobel; Peter F Zipfel; Mihály Józsi Journal: Mol Immunol Date: 2009-07-28 Impact factor: 4.407
Authors: F Vaziri-Sani; L Holmberg; A G Sjöholm; A-C Kristoffersson; M Manea; V Frémeaux-Bacchi; I Fehrman-Ekholm; R Raafat; D Karpman Journal: Kidney Int Date: 2006-03 Impact factor: 10.612
Authors: Katherine A Vernon; Marieta M Ruseva; H Terence Cook; Marina Botto; Talat H Malik; Matthew C Pickering Journal: J Am Soc Nephrol Date: 2015-09-15 Impact factor: 10.121
Authors: An S De Vriese; Sanjeev Sethi; Jens Van Praet; Karl A Nath; Fernando C Fervenza Journal: J Am Soc Nephrol Date: 2015-07-16 Impact factor: 10.121
Authors: Marcell Cserhalmi; Barbara Uzonyi; Nicolas S Merle; Dorottya Csuka; Edgar Meusburger; Karl Lhotta; Zoltán Prohászka; Mihály Józsi Journal: Front Immunol Date: 2017-12-13 Impact factor: 7.561